Search by Drug Name or NDC

    NDC 61703-0363-18 Oxaliplatin 5 mg/mL Details

    Oxaliplatin 5 mg/mL

    Oxaliplatin is a INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is OXALIPLATIN.

    Product Information

    NDC 61703-0363
    Product ID 61703-363_9b334968-cb6e-4119-b6a7-a9f5c18add5b
    Associated GPIs 21100028002025 21100028002030
    GCN Sequence Number 059162
    GCN Sequence Number Description oxaliplatin VIAL 50 MG/10ML INTRAVEN
    HIC3 V1A
    HIC3 Description ANTINEOPLASTIC - ALKYLATING AGENTS
    GCN 24699
    HICL Sequence Number 016687
    HICL Sequence Number Description OXALIPLATIN
    Brand/Generic Generic
    Proprietary Name Oxaliplatin
    Proprietary Name Suffix n/a
    Non-Proprietary Name OXALIPLATIN
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION, CONCENTRATE
    Route INTRAVENOUS
    Active Ingredient Strength 5
    Active Ingredient Units mg/mL
    Substance Name OXALIPLATIN
    Labeler Name Hospira, Inc.
    Pharmaceutical Class Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078813
    Listing Certified Through 2024-12-31

    Package

    NDC 61703-0363-18 (61703036318)

    NDC Package Code 61703-363-18
    Billing NDC 61703036318
    Package 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-363-18) / 10 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2009-08-10
    NDC Exclude Flag N
    Pricing Information N/A